CN1136907C - Making process of enzyme degrading oral liquid - Google Patents
Making process of enzyme degrading oral liquid Download PDFInfo
- Publication number
- CN1136907C CN1136907C CNB01141376XA CN01141376A CN1136907C CN 1136907 C CN1136907 C CN 1136907C CN B01141376X A CNB01141376X A CN B01141376XA CN 01141376 A CN01141376 A CN 01141376A CN 1136907 C CN1136907 C CN 1136907C
- Authority
- CN
- China
- Prior art keywords
- parts
- weight portions
- preparation
- liquor
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a preparation method of an oral liquor for reducing enzyme, which belongs to the technical field of a preparation method of a Chinese medicinal preparation. The existing Chinese medicinal preparation for treating glutamic pyruvic transaminase increase caused by various hepatitides has the disadvantages of not ideal effect, long course of treatment, low effective rate of treatment and low cure rate. The preparation method has the technical scheme that the oral liquor is prepared from the raw materials of 15 to 25 parts of rhubarb, 15 to 20 parts of capillary wormwood herb, 15 parts of giant knotweed rhizome, 6 to 10 parts of northern vietnamese sophora root, 15 to 20 parts of red sage root, 15 parts of forsythia fruit, 25 to 30 parts of oldenlandia, 6 to 9 parts of gentian root, 15 to 20 parts of therapeutic schisandra fruit, 15 to 20 parts of isatis root, 15 to 20 parts of dandelion and 20 to 30 parts of stringy stonecrop herb according to parts by weight. The raw materials are pulverized, uniformly stirred, poured into a medicine pot and decocted for a period of time after boiling, and a first physic liquor is obtained by filtration; then, water is added again, the raw materials are decocted for a period of time, and a second physic liquor is obtained by filtration; the first physic liquor and the second physic liquor are mixed to prepare the oral liquor for reducing enzyme. The preparation method has the advantage of simple technology. The prepared oral liquor has the advantages of short course of treatment for patients with hepatitides, high effective rate and high cure rate.
Description
Technical field: the invention belongs to Chinese medicine preparation manufacture method technical field, is a kind of making process of enzyme degrading oral liquid more specifically.
Background technology: it is undesirable at present to treat the Glutamate pyruvate transaminase rises effect that various hepatitis cause with Chinese medicine preparation, and subject matter is: the long financial burden that the has increased patient course of treatment, the low often recurrence easily of treatment effective percentage and cure rate.
Summary of the invention:, the objective of the invention is to invent a kind of enzyme degrading oral liquid for overcoming above-mentioned shortcoming.Its technical scheme is: get Radix Et Rhizoma Rhei 15～25 weight portions, Herba Artemisiae Scopariae 15～20 weight portions, Rhizoma Polygoni Cuspidati 15 weight portions, Beishan Mountain Radix Sophorae Tonkinensis 6～10 weight portions, Radix Salviae Miltiorrhizae 15～20 weight portions, Fructus Forsythiae 15 weight portions, Herba Hedyotidis Diffusae 25～30 weight portions, Radix Gentianae 6～9 weight portions, Fructus Schisandrae Chinensis 15～20 weight portions, Radix Isatidis 15～20 weight portions, Herba Taraxaci 15～20 weight portions and Herba Sedi 20～30 weight portions, after pulverizing is mixed all, pour in the medicine pot and add water, decoct, leach medicinal liquid for the first time; And then add water, and decoct, leach medicinal liquid for the second time; At last medicinal liquid for the first time and for the second time is mixed and made into enzyme degrading oral liquid.Advantage of the present invention is: manufacture method is simple, and the component preparation in the prescription is particular about scientific and reasonable.Herba Artemisiae Scopariae is a feverfew, is that the key medicine and the Radix Gentianae (being gentianaceae plant) of promoting the function of the gallbladder to alleviate jaundice share better efficacy; Herba Taraxaci (being feverfew), Radix Isatidis (being crucifer) and Beishan Mountain Radix Sophorae Tonkinensis (being leguminous plant) have clearing away damp-heat, kill the virus, and use in conjunction has strengthened antivirus action greatly, and Herba Taraxaci has the function of regulating the autoimmune ability again; Radix Salviae Miltiorrhizae (being lip section plant) has the HUOXUEHEXUE effect, and promptly blood circulation promoting and blood stasis dispelling blood trouble not again can be improved the key medicine of liver vessel microcirculation for the treatment hepatopathy again; Radix Et Rhizoma Rhei (the being polygonaceae plant) poison that can function of gallbladder promoting goes out makes toxin rush down down outstanding sharp word from stool; Herba Sedi (being the Crassulaceae plant) and treatment Fructus Schisandrae Chinensis (chain timbers orchid) tonifying liver effect of reducing enzyme levels are more outstanding.Wherein 64 routine patient's statistics of this oral liquid treatment, male 53 people, women 11 people, oldest 52 years old, minimum 8 years old, average 29.3 years old.The elder of sick time 7 years is surplus, glutamate pyruvate transaminase soprano 508 units, and the lowest 45 units, average 161 units are diagnosed as early stage hepatitis person's 7 examples of acute viral through debating disease, appearance sclera jaundice are in various degree all arranged, extremity fatigue and weak inappetence.Hepatitis B 57 examples wherein belong to acute hepatitis B 4 examples, chronic hepatitis B 53 examples, and hepatitis B all has the myasthenia of limbs inappetence, symptoms such as urine jaundice.Therapeutic Method: this is organized 64 examples and is family's isolation, and enzyme degrading oral liquid is adopted in out-patient treatment, stops other all medicines during treating, and is 14 days two courses of treatment with the enzyme degrading oral liquid maximum duration, and the shortest time is 7 days courses of treatment.Usage: twice of every day, sooner or later on an empty stomach respectively once, each about 450～500 milliliters, 250～300 milliliters of child's decrements, glutamate pyruvate transaminase soprano 55 units after treating, the lowest 1 constituent parts, effective percentage reaches 100%, and clinical cure rate reaches 98.4%, mean treatment 11.7 days, glutamate pyruvate transaminase drops to normal level 63 people, and above-mentioned symptom disappears.Therefore this oral liquid treatment hepatitis patient effective percentage and cure rate height, general 7～14 days of short treating period, the Chinese medicine medicine source cost that extensively is easy to get is low.
The specific embodiment: get Radix Et Rhizoma Rhei 20 gram, Herba Artemisiae Scopariae 18 grams, Rhizoma Polygoni Cuspidati 15 grams, Beishan Mountain Radix Sophorae Tonkinensis 7 grams, Radix Salviae Miltiorrhizae 18 grams, Fructus Forsythiae 15 grams, Herba Hedyotidis Diffusae 26 grams, Radix Gentianae 7 grams, Fructus Schisandrae Chinensis 18 grams, Radix Isatidis 17 grams, Herba Taraxaci 17 grams and Herba Sedi 25 grams and after pulverizing is mixed all, pour into and add 450 milliliters in water in the medicine pot, endured after boiling 3 minutes, and leached medicinal liquid for the first time; And then add 450 milliliters in water, and endured after boiling 3 minutes, leach medicinal liquid for the second time; Twice medicinal liquid is mixed and made into enzyme degrading oral liquid.
Claims (1)
1, making process of enzyme degrading oral liquid, it is characterized in that: get Radix Et Rhizoma Rhei 15～25 weight portions, Herba Artemisiae Scopariae 15～20 weight portions, Rhizoma Polygoni Cuspidati 15 weight portions, Beishan Mountain Radix Sophorae Tonkinensis 6～10 weight portions, Radix Salviae Miltiorrhizae 15～20 weight portions, Fructus Forsythiae 15 weight portions, Herba Hedyotidis Diffusae 25～30 weight portions, Radix Gentianae 6～9 weight portions, Fructus Schisandrae Chinensis 15～20 weight portions, Radix Isatidis 15～20 weight portions, Herba Taraxaci 15～20 weight portions and Herba Sedi 20～30 weight portions, after pulverizing is mixed all, pour in the medicine pot and add water, decoct, leach medicinal liquid for the first time; And then add water, and decoct, leach medicinal liquid for the second time; At last medicinal liquid for the first time and for the second time is mixed and made into enzyme degrading oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01141376XA CN1136907C (en) | 2001-10-25 | 2001-10-25 | Making process of enzyme degrading oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01141376XA CN1136907C (en) | 2001-10-25 | 2001-10-25 | Making process of enzyme degrading oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1349823A CN1349823A (en) | 2002-05-22 |
| CN1136907C true CN1136907C (en) | 2004-02-04 |
Family
ID=4676120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB01141376XA Expired - Fee Related CN1136907C (en) | 2001-10-25 | 2001-10-25 | Making process of enzyme degrading oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1136907C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100450507C (en) * | 2006-08-17 | 2009-01-14 | 江智文 | Chinese traditional medicine and western medicine composition for treating hepatitis |
| CN101837064B (en) * | 2010-05-11 | 2011-08-31 | 李国� | Epomediol-containing medicament composition for protecting liver and decreasing enzyme |
| CN104721352B (en) * | 2014-12-20 | 2018-03-16 | 熊安富 | A kind of Chinese medicine for treating hepatitis B |
| CN104873882A (en) * | 2015-04-24 | 2015-09-02 | 安徽智远生物科技有限公司 | Traditional Chinese medicine for treating jaundice hepatitis |
| CN108420895A (en) * | 2018-05-22 | 2018-08-21 | 王宏奎 | For reducing the pharmaceutical composition and preparation method thereof of glutamic-pyruvic transaminase |
| CN110787258A (en) * | 2019-11-27 | 2020-02-14 | 王同生 | A Chinese medicinal composition for treating diabetes, and its preparation method |
-
2001
- 2001-10-25 CN CNB01141376XA patent/CN1136907C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1349823A (en) | 2002-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN1112201C (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
| CN103721190B (en) | A kind of cyst type acne mixture | |
| CN103316305B (en) | Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof | |
| CN101991780A (en) | Chinese material medical preparation for treating apoplexy | |
| CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
| CN1136907C (en) | Making process of enzyme degrading oral liquid | |
| CN1616068A (en) | Chinese medicine decoction for treating neck-shoulder and waist-leg pain | |
| CN1994453B (en) | Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN101130053A (en) | Traditional Chinese medicine for treating exogenous injury type blood stasis headache | |
| CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
| CN103623385A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN100998719B (en) | Oral traditional Chinese medicine for treating amenorrhea of stagnancy qi and blood stasis type | |
| CN103316283B (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
| CN1094057C (en) | Liver ascites treating medicine | |
| CN101658652A (en) | Chinese medicinal preparation for treating chronic appendicitis | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN112587640B (en) | Traditional Chinese medicine composition for relieving tumor cachexia | |
| CN1994415B (en) | Orally administered Chinese medicine for treating dysmenorrhea | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN1382486A (en) | Fengshitongluo wan for treating rheumatism | |
| CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |